A carregar...
A review of glycemic efficacy of liraglutide once daily in achieving glycated hemoglobin targets compared with exenatide twice daily, or sitagliptin once daily in the treatment of type 2 diabetes
Incretin-based therapies such as glucagon-like peptide-1 (GLP-1) receptor agonists (RA) and dipeptidyl peptidase-4 (DPP-4) inhibitors have gained prominence in recent years for the treatment of type 2 diabetes (T2D). Such therapies offer the potential to stimulate endogenous insulin activity in prop...
Na minha lista:
| Publicado no: | Saudi Med J |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Saudi Medical Journal
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5018698/ https://ncbi.nlm.nih.gov/pubmed/27464858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15537/smj.2016.8.15800 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|